Malignancies in Inflammatory Bowel Disease: Fact or Fiction?

References

• Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Cancer morbidity in ulcerative colitis. Gut 1982; 23:490–7.
   PubMed Web of Science ®Google Scholar
• Farrell RJ, Ang Y, Kileen P, Obriain DS, Kelleher D, Keeling PWN, et al. Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 2000 ; 47:514–9.
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK, Olsen JH. Crohn’s disease and cancer risk (Denmark). Cancer Cause Control 2000;11:145–50.
   PubMed Web of Science ®Google Scholar
• Bargen JA. Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928;17:561–76.
   Google Scholar
• Brostrom O, Löfberg R, Nordenvall B, Ost A, Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologi c study. Scand J Gastroenterol 1987;22:1193–9.
   PubMed Web of Science ®Google Scholar
• Greenstein A, Sachar DB, Smith H, Pucillo A, Papatestas AE, Kreel I, et al. Cancer in universal and left-sided ulcerative colitis : factors determining risk. Gastroenterology 1979;77:290–4.
   PubMed Web of Science ®Google Scholar
• Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206–17.
   PubMed Web of Science ®Google Scholar
• Johnson WR, McDermott FT, Hughes ESR, Pihl EA, Milne BJ. The risk of rectal carcinoma following colectomy in ulcerative colitis. Dis Colon Rectum 1983;26:44–6.
   PubMedGoogle Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-base d study. N Engl J Med 1990; 323:1228–33.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterolog y 1992;103:1444–51.
   PubMed Web of Science ®Google Scholar
• de Dombal FT, Watts MCKJ, Watkinson G, Goligher JC. Local complications of ulcerative colitis: stricture, pseudopoliposi s and carcinoma of colon and rectum. Br Med J 1966;1:1442–7.
   PubMed Web of Science ®Google Scholar
• Wandall EP, Damkier P, Pedersen FM, Wilson B, Demuckadell OBS. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen County diagnosed between 1973 and 1993. Scand J Gastroenterol 2000;35: 312–7.
   Google Scholar
• Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241–8.
   Google Scholar
• Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH Jr, Greenstein A. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167–9.
   Google Scholar
• Lashner BA, Turner BC, Bostwick DG, Frank PH, Hanauer SB. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990;35:349–52.
   Google Scholar
• Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938–41.
   Google Scholar
• Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996;110:432–40.
   PubMed Web of Science ®Google Scholar
• Olsson R, Danielsson A, Järnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319–23.
   Google Scholar
• Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population-based study. Gut 1997;41:522–5.
   Google Scholar
• Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study. Gastroenterology 1994;107:117–20.
   Google Scholar
• Moody GA, Jayanthi V, Probert CSJ, Mackay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996;8:1179–83.
   Google Scholar
• Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000;14:145–53.
   Google Scholar
• Riddell RH, Goldman H, Ransohoff DF, Appleman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 1983;14:931–68.
   PubMed Web of Science ®Google Scholar
• Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;28:383–8.
   Google Scholar
• Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994;35: 1419–23.
   PubMed Web of Science ®Google Scholar
• Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950–6.
   Google Scholar
• Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992;103:431–8.
   Google Scholar
• Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001;120:841–7.
   PubMed Web of Science ®Google Scholar
• Warren S, Sommers SC. Cicatrizing enteritis (regional enteritis) as a pathologic entity: analysis of one hundred and twenty cases. Am J Pathol 1948;24:475–501.
   PubMedGoogle Scholar
• Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WR. Crohn’s disease and cancer. N Engl J Med 1973;289:1099–102.
   PubMed Web of Science ®Google Scholar
• Greenstein A, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. Patterns of neoplasia in Crohn’s disease and ulcerative colitis. Cancer 1980;46:405–7.
   Google Scholar
• Greenstein A, Sachar DB, Smith H, Janowitz HD, Aufses AH, Jr. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981;48:2742–5.
   PubMed Web of Science ®Google Scholar
• Sachar DB. New concepts of cancer. Mt Sinai J Med 1983;50: 133–7.
   Google Scholar
• Sachar DB. Cancer in Crohn’s disease: Dispelling the myths. Gut 1994;35:1507–8.
   PubMed Web of Science ®Google Scholar
• Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590–2.
   Google Scholar
• Gillen CD, Andrews HA, Prior P, Allan RN . Crohn’s disease and colorectal cancer. Gut 1994;35:651–5.
   Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990;336:357–9.
   PubMed Web of Science ®Google Scholar
• Bernstein D, Rogers A. Malignancy in Crohn’s disease. Am J Gastroentero l 1996;91:434–40.
   Google Scholar
• Codling BW, Keighley MRB, Slaney G. Hodgkin’s disease complicating Crohn’s colitis. Surgery 1977;82:625–8.
   Google Scholar
• Fielding JF, Prior P, Waterhouse JA, Cooke WT. Malignancy in Crohn’s disease. Scand J Gastroenterol 1972;7:3–7.
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Mullin GE, Strauchen JA, Heimann T, Janowitz HD, Aufses AH, Jr., et al. Lymphoma in inflammatory bowel disease. Cancer 1992;69:1119–23.
   Google Scholar
• Lenzen R, Borchard F, Lubke H, Strohmeyer G. Colitis ulcerosa complicated by malignant lymphoma: case report and analysis of published works. Gut 1995;36:306–10.
   Google Scholar
• Wilkinson AH, Smith JC, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplantation 1989;47:293–6.
   PubMed Web of Science ®Google Scholar
• Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1992;342:1514–6.
   Google Scholar
• Asten P, Marrett J, Symmons D. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 1999; 26:1705–14.
   Google Scholar
• Palli D, Trallori G, Bagnoli S, Saieva C, Tarantino O, Ceroti M, et al. Hodgkin’s disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000;119:647–53.
   PubMed Web of Science ®Google Scholar
• Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn’s disease. Gastroenterology 1999;117: 1433–7.
   Google Scholar
• Löfberg R, Rutgeerts P, Van Deventer SJH, Van Hogezand, R, Schaible T, De Woody K, et al. Long-term safety follow up of patients treated with infliximab (anti-TNFα antibody, Remicade®) in clinical trials (Abstract). Gut 2000;70 Suppl A245.
   Google Scholar